NSEGeneral Updates12h ago · 18 Nov 2026, 07:38 pm

General Updates

Jubilant Pharmova Limited · JUBLPHARMA

✦ AI Summary

Jubilant Pharmova Limited has informed the Exchange about General Updates regarding the Grant of 1,907 Restricted Stock Units (RSUs) to eligible employees under the Jubilant Pharmova Employees Stock Option Plan 2018.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Jubilant Pharmova Limited has informed the Exchange about General Updates

Attachments (1)

📄

JUBLPHARMA_18112026193739_DRAFT_ESOP_Disclosure1.pdf

pdf

Download →
View document text
November 18, 2026 BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers Exchange Plaza Dalal Street, Fort Bandra Kurla Complex Mumbai - 400 001 Bandra (E) Mumbai - 400 051 Equity Scrip Code: 530019 Trading Symbol: JUBLPHARMA Debt Scrip Code: 978381 Sub: Regulation 30 and Regulation 51 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") Dear Sir/Madam, Pursuant to the provisions of Regulation 30 and Regulation 51 of the Listing Regulations, we wish to inform you that the members of the Nomination, Remuneration and Compensation Committee of the Company has, today, i.e. on Wednesday, November 18, 2026, inter alia, approved the Grant of 1,907 Restricted Stock Units (RSUs) to the eligible employees under the Jubilant Pharmova Employees Stock Option Plan 2018. Date & Time: November 18, 2026, 7:27 PM Details pursuant to Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are provided in attached Annexure. The above- mentioned documents will be simultaneously posted on the Company's website at www.jubilantpharmova.com. You are requested to kindly take the same on record. Thanking you, Yours faithfully, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary Annexure Disclosure of information pursuant to Regulation 30 and 51 of the Listing Regulations read with SEBI Master Circular dated January 30, 2026: 1 Brief details of options granted Grant of 1,907 RSUs to the eligible employee as determined by the Nomination, Remuneration and Compensation Committee 2 Whether the scheme is in terms of Yes SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 3 Total number of shares covered by 1,907 Equity Shares of face value Re. 1 each. these options 4 Pricing Formula (Exercise Price) For 1,907 RSUs, the Exercise Price is Re. 1 each i.e. face value per equity share of the Company 5 Options Vested (Vesting Schedule) Subject to fulfilment of pre-vesting conditions, RSUs will vest as under: Vesting Criteria of 1,907 RSUs of Re. 1: 3 years from the date of grant based on performance 6 Time within which option may be 1,907 RSUs shall be exercisable within a exercised (Exercised Period) maximum period of 1 (one) year from the date of vesting, subject to the terms of Jubilant Pharmova Employees Stock Option Plan 2018. 7 Brief details of significant terms 1 RSU is equal to 1 equity share. RSUs are granted based on tenure and rating of employee. Note: The requirements prescribed under sub-clauses (g) to (k), (m) & (n) of Clause 10 of Para B of Annexure I of SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are not applicable.